Metastatic non-clear cell renal cell carcinoma

Clinical trials for Metastatic non-clear cell renal cell carcinoma explained in plain language.

Never miss a new study

Get alerted when new Metastatic non-clear cell renal cell carcinoma trials appear

Sign up with your email to follow new studies for Metastatic non-clear cell renal cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Immune-Drug combo aims to shrink rare kidney tumors before surgery

Disease control Not yet recruiting

Researchers are testing two drugs, toripalimab and axitinib, in adults with advanced non-clear cell kidney cancer or renal medullary carcinoma who have not received prior treatment and still have their primary kidney tumor. Everyone receives the drugs for about 12 weeks. Then a t…

Matched conditions: METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA

Phase 2 • Sponsor: Fudan University • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC

Metastatic non-clear cell renal cell carcinoma

Get alerted when new Metastatic non-clear cell renal cell carcinoma trials appear

Immune-Drug combo aims to shrink rare kidney tumors before surgery